In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed for diabetes that are now being used to help people lose significant ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

GLP-1 agonists are medications that primarily treat type 2 diabetes and obesity. However, recent studies suggest they can lower blood pressure, reduce inflammation and improve lipid disorders.